Dr. Tarun Narang
Designation : Additional Professor
Department : DERMATOLOGY VENEREOLOGY LEPROLOGY
Narang.tarun@pgimer.edu.in , narangtarun@yahoo.com

 
 
 :: Educational Qualification
  Graduation :   MBBS from GMCH CHANDIGARH in year 1998
  Post Graduation :   MD from PGIMER CHANDIGARH in year 2004
  Other Qualification.(1)      :   MNAMS from National Academy of Medical Sciences in year 2017
  Other Qualification.(2)      :   FRCP from Edinburg in year 2023
     
 :: Area of Interest
       Area Of Interest       :
Leprosy,Psoriasis, Psychodermatology, Dermatosurgery
  • Leprosy, Psoriasis, Psychodermatology, neglected tropical diseases of skin ( subcutaneous mycoses, mycetoma, leishmaniasis, cuateous tuberculosis and NTMs)
     
 :: Research & Projects
      Extramural Projects       :
To study the efficacy and safety of 2nd line antileprosy drugs in the management of type 2 reactions in leprosy

  • An open label assessor-blind phase III 3-arm, multi-centric, randomized controlled study trial to evaluate the immunotherapeutic efficacy of Mycobacterium Indicus Pranni (MIP) vaccine, Bacille Calmette Guerin (BCG) vaccine as an adjunct to chemotherapy in Multibacillary (MB) patients of leprosy.

  • Comparison of WHO MDT (MBR) vs Alternate Leprosy Treatment (ALT) efficacy in MB leprosy patients by assessing anti PGL-1 antibodies and viable bacterial load pre and post multidrug therapy.
  • To evaluate the role of fungal virulence, pharmacokinetics and pharmacodynamics of terbinafine in chronic/ recurrent or relapse dermatophytosis by T. mentagrophytes complex.

  • Exploring Erythema Nodosum Leprosum (ENL)-specific regulatory networks using RNA sequencing-based longitudinal transcriptomic approach.
      Departmental / P.G.I.
      Projects      		 :
1. behavioral  adverse effects of steroids.
2. psychological comorbidity in patients with Psoriasis compared with endogenous eczema.
3. A prospective study to assess the economic burden (direct and indirect costs) and quality of life in patients of Neglected tropical diseases (Cutaneous Leishmaniasis, Mycetoma, subcutaneous mycoses, and cutaneous TB) in a tertiary center in North India.
4. Quality of life and Out of pocket expenditure for treatment of Leprosy in the tertiary care institute of North India.

      Area Of
      Specialization      		 :

Neglected tropical diseases, Leprosy, Psoriasis, Psychodermatology

      Awards & Honours       :

·                    BAD travel grant to present paper/ poster inAnnual meeting of British Academy of Dermatologists in July 2007 in Birmingham(UK)

·                    International League of DermatologicalSocieties (ILDS) scholarship to attend 21st World Congress of Dermatology 2007,October 1-5 at Buenos Aires, Argentina.

·                    Imrich Sarkany Non-European Exceptional Casesgrant awarded by European Academy of Dermatologists and Venereologists in 2008to attend EADV in Paris , France

·                    ICD 2009 Scholarship to attend the 10thInternational Congress of Dermatology to be held in May 20 - 24, 2009 inPrague, Czech Republic

·                    Gold medal for e-poster in WCD2011 Seoul,Korea. Efficacy  and safety of topicalbimatoprost solution 0.03% in stable vitiligo. A preliminary study.

·                    ICMR Grant for Poster presentation in 3rdWorld Psoriasis and Psoriatic Arthritis conference 2012, Stockholholm, Sweden.

BAD travel grant to present paper/ poster in Annualmeeting of British Academy of Dermatologists in July 2013 in Liverpool (UK)

·Imrich Sarkany Non-European Exceptional Casesgrant awarded by European Academy of Dermatologists and Venereologists in 2008to attend EADV in Paris , France

  • Gold medal for e-poster in WCD2011 Seoul,Korea. Efficacy  and safety of topicalbimatoprost solution 0.03% in stable vitiligo. A preliminary study.

  • Prof. G Senthalmil Selvi Award for best-published paper in Mycology 2020

    •          IADVL Abbot Researcher Award (>35 years) 2020

    •          IADVL Prof VN Sehgal Award, 2022
      Member Of Professional
      Bodies      		 :
Indian Association of DermatologistsVenereologists and Leprologists
  • Contactand Occupational Dermatoses Forum of India
  • EuropeanAcademy of Dermatology and Venereology
  • Indian Association of Leprologists

  • Psychodermatology society of India

  • American Society of Tropical Medicineand Hygiene

  • GRAPPA

  • National Academy of Medical Sciences
     
 :: Publications(In Vancouver Style)

Total number of publications                                      

Indexed                                                                                   247

Non indexed                                                                            27

Total number of citations                                                         3139   

H-Index                                                                                    29

Publication list

  1. Kumar B, Narang T, Radotra BD, Gupta S. Mondor's disease of penis: a forgotten disease. Sex Transm Infect. 2005 Dec;81(6):480-2.
  2. Kumar B, Narang T, Gupta S and Gulati M. A clinico-aetiological and ultrasonographic study of Peyronie’s disease.  Sexual Health 3(2) 113–118.
  3. Narang T, Kaur I, Kumar B, Radotra B.D and  Dogra S. Comparative evaluation of BCG and Mw vaccines in patients of multibacillary leprosy. Int J Lepr Other Mycobact Dis. 2005 Jun;73(2):105-14.
  4. Narang T, Kaur I and Dogra S. Borderline Tuberculoid Leprosy with type 1 reaction in a HIV patient – a phenomenon of immune reconstitution. . Int J Lepr Other Mycobact Dis. 2005 Sep;73(3):203-5.
  5. Kanwar AJ,Ajith C,  Narang T. Pemphigus in North India. J Cutan Med Surg. 2006 Jan-Feb; 10(1):21-5.
  6. Kumar B, Narang T, Radotra BD, Gupta S. Plasma Cell Balanitis: Clinicopathologic Study of 112 Cases and Treatment Modalities. J Cutan Med Surg. 2006 Jan-Feb; 10(1):11-5.
  7. Handa S, Narang T, Wanchu A. Dermatologic immune restoration syndrome: report of five cases from a tertiary care center in north India. J Cutan Med Surg. 2008 May-Jun;12(3):126-32.
  8. Kaur I,Dogra S, Narang T ,De D. Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: A randomized study. Australasian Journal of Dermatology (2009) 50, 181–185._534 18.
  9. Gupta  M, Narang T .Role of mitomycin C in reducing keloid recurrence: patient series and literature review. Journal of Laryngology and Otology 2010,  1-4.

10.  KumarB, Narang T Local andsystemic adverse effects to topical imiquimod due to systemic immunestimulation.. Sex Transm Infect. 2011Aug;87(5):432.

  1. Dogra S, Narang T, Kumar B. Leprosy eradication: evolution of the path to eradication. Indian J Med Res 137, January 2013, pp 74-94.
  2. Dogra S, Sendhil Kumaran MS, Narang T, Radotra BD*, Kumar B.  Epidemiological characteristics and clinical outcome in multibacillary leprosy patients treated with 12 months WHO MDT-MBR at a referral hospital in Northern India: a retrospective analysis of 730 patients . Lepr Rev. 2013 Mar;84(1):65-75.
  3. Yadav S, Narang T, Sendhil Kumaran MS. Psychodermatology: a comprehensive review. Indian J Dermatol Venereol Leprol. 2013 Mar-Apr;79(2):176-92.
  4. Kaur M, Narang T, Bala M, Gupte S, Aggarwal P, Manhas A. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tertiary Care Hospital, Punjab. Indian J Med Microbiol. 2013 Jul-Sep;31(3):270-4.
  5. Mahajan R, Kumaran MS, Narang T, Handa S, Dogra S. Genital psoriasis among Indians: A prospective cross-sectional study. Australas J Dermatol. 2013 Jun 28.
  6. Kanwar AJ, Narang T. Anagen effluvium. Indian J Dermatol Venereol Leprol. 2013;79(5):604-12.

17.  SendhilKumaran M, Narang T, Dogra S, Saikia UN, Kanwar A J. Nevus lipomatosussuperficialis unseen or unrecognized: a report of eight cases. J Cutan Med Surg. 2013 Oct 1;17(5):335-9

18.  NarangT, Kumaran MS, Dogra S, Saikia UN, Kumar B. Red scrotum syndrome:idiopathic neurovascular phenomenon or steroid addiction?Sex Health. 2013 Sep 13. doi: 10.1071/SH13052

19.  KanwarAJ, Narang T. Adultonset atopic dermatitis: Under-recognized or under-reported? Indian Dermatol Online J. 2013 Jul;4(3):167-71.

    • S Yadav, T Narang, MS Kumaran. Psychodermatology:A comprehensive review. Indian journal of dermatology, venereology andleprology 79, 176.

    B Kumar, T Narang, BD Radotra, S Gupta.Mondor’s disease of penis: a forgotten disease. Sexually transmitted infections81 (6), 480-482       86        2005

    S Dogra, T Narang. Emerging atypicaland unusual presentations of dermatophytosis in India. Clinical DermatologyReview 1 (Suppl 1), S12-S18    81        2017

    I Kaur, S Dogra, T Narang, D De.Comparative efficacy of thalidomide and prednisolone in the treatment of moderateto severe erythema nodosum leprosum: a randomized study. Australasian journalof dermatology 50 (3), 181-185     69            2009

    T Narang, M Daroach, MS Kumaran.Efficacy and safety of topical calcipotriol in management of alopecia areata: Apilot study. Dermatologic Therapy 30 (3), e12464  53        2017

    B Kumar, T Narang, BD Radotra, S Gupta.Plasma cell balanitis: clinicopathologic study of 112 cases and treatmentmodalities. Journal of Cutaneous Medicine and Surgery 10 (1), 11-15 53        2006

    SDogra, T Narang, G Khullar, R Kumar, UN Saikia. Childhood leprosy through thepost-leprosy-elimination era: a retrospective analysis of epidemiological andclinical characteristics of disease over eleven years from a … Leprosy review85 (4), 296-310            48        2014

    T Narang, R Bhattacharjee, S Singh, KJha, Kavita, R Mahajan, S Dogra. Quality of life and psychological morbidity inpatients with superficial cutaneous dermatophytosis. Mycoses 62 (8), 680-685

    T Narang, B Kumar. Leprosy in children.Indian Journal of Paediatric Dermatology 20 (1), 12-24

    T Narang, MS Kumaran, S Dogra, UNSaikia, B Kumar Red scrotum syndrome: idiopathic neurovascular phenomenon orsteroid addiction?Sexual Health 10 (5), 452-455

    Kumar B, Narang T, Radotra BD, Gupta S.Mondor's disease of penis: a forgotten disease. Sex Transm Infect. 2005Dec;81(6):480-2.

    T Narang, I Kaur, B Kumar, BD Radotra,S Dogra. Comparative evaluation of immunotherapeutic efficacy of BCG and mwvaccines in patients of borderline lepromatous and lepromatous leprosy. Internationaljournal of leprosy and other mycobacterial diseases 73 (2), 105     40        2005

    K Vinay, D Kamat, D Chatterjee, TNarang, S Dogra. Dermatoscopy in leprosy and its correlation with clinicalspectrum and histopathology: a prospective observational study. Journal of theEuropean Academy of Dermatology and Venereology 33 (10), 1947

    Kumar B, Narang T, Radotra BD, Gupta S.Plasma Cell Balanitis: Clinicopathologic Study of 112 Cases and TreatmentModalities. J Cutan Med Surg. 2006 Jan-Feb; 10(1):11-5.

    TP Afra, M Razmi, T Narang, S Dogra, AKumar. Topical tazarotene gel, 0.1%, as a novel treatment approach for atrophicpostacne scars: a randomized active-controlled clinical trial. JAMA facialplastic surgery 21 (2), 125-132       33            2019

    M Gupta, T Narang. Role of mitomycin Cin reducing keloid recurrence: patient series and literature review. TheJournal of Laryngology & Otology 125 (3), 297-300

    Handa S, Narang T, Wanchu A.Dermatologic immune restoration syndrome: report of five cases from a tertiarycare center in north India. J Cutan Med Surg. 2008 May-Jun;12(3):126-32.

    T Narang, A Kaushik, S Dogra. Apremilastin chronic recalcitrant erythema nodosum leprosum: a report of two cases. BritishJournal of Dermatology 182 (4), 1034-1037

    M Gupta, T Narang, RJ Kaur, A Manhas,UN Saikia, S Dogra A prospective case series evaluating efficacy and safety ofcombination of itraconazole and potassium iodide in rhinofacialconidiobolomycosis. International Journal of Dermatology 55 (2), 208-214.

    Kavita, JS Thakur, T Narang The burdenof skin diseases in India: Global Burden of Disease Study 2017. Indian Journalof Dermatology, Venereology and Leprology 89 (3), 421-425.

    T Narang, A Bishnoi, S Dogra, UN Saikia.Alternate anti-leprosy regimen for multidrug therapy refractory leprosy: aretrospective study from a tertiary care center in North India.The AmericanJournal of Tropical Medicine and Hygiene 100 (1), 24

    T Narang, D Kamat, V Thakur, M Lavania,I Singh, M Ahuja, S Dogra .Equal rates of drug resistance in leprosy cases withrelapse and recurrent/chronic Type 2 reaction: time to revise the guidelinesfor drug‐resistance testing in leprosy? Clinical andExperimental Dermatology 47 (2), 297-302